The clinical complexity arising from the phenotypic differences between XP, CS, TTD, and their combined disorders can be explained on the basis of which process(es) is/are affected and to what extent: GG-NER in XP, TC-NER in CS, and transcription initiation for TFIIH mutations. The gene discussed is ERCC2; the disease is xeroderma pigmentosum.